Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 12-2017 | |
| Operating Expenses | 5,407 | 0 | 0 |
| Operating Income | -5,407 | N/A | N/A |
| Other Income | 106 | 0 | 0 |
| Pre-tax Income | -5,301 | 0 | 0 |
| Income Tax | -52 | 0 | N/A |
| Net Income Continuous | -5,249 | 0 | N/A |
| Net Income | $-5,249 | $0 | $N/A |
| EPS Basic Total Ops | -22.35 | N/A | N/A |
| EPS Basic Continuous Ops | -17.44 | N/A | N/A |
| EPS Diluted Total Ops | -22.35 | N/A | N/A |
| EPS Diluted Continuous Ops | -17.44 | N/A | N/A |
| EBITDA(a) | $-5,377 | $N/A | $N/A |